Proceedings of the PSK Conference (대한약학회:학술대회논문집)

The Pharmaceutical Society of Korea (대한약학회)
권호 표지

Clinical Effects of Gemcitabine and 5-Fluorouracil Combination therapy and Epirubicin. Cisplatin. and 5-Fluorouracil Combination therapy for patients with Pancreatic Cancer

  • Her, Sook (Graduate School of Pharmacy. Sookmyung Women′s University) ;
  • Lee, Suk-Hyung (Graduate School of Pharmacy. Sookmyung Women′s University) ;
  • Kang, Jin-Hyoung (Graduate School of Pharmacy. Sookmyung Women′s University)
  • Published : 2002.10.01
Download PDF
⟨ Previous Next ⟩

Abstract

Gemcitabine demonstrated modest activity in locally advanced and metastatic pancreatic cancer with difficulty early diagnosis and poor prognisis. The purpose of this study was to evaluate the efficacy and toxicity of gemcitabine and 5-fluorouracil(GF) combination theraphy and epirubicin. cisplatin. and 5-fluorouracil(ECF) combination theraphy for the patients with locally advanced or metaststic pancreatic cancer. Between January 1996 and December 2001. (omitted)

Keywords